Skip to content

Evaluation of symptoms, respiratory, pulmonary image and inflammation in patients who have been hospitalized for coronavirus infection in the period of a year, multicentric study (fenix)

Evaluation of clinical symptoms, respiratory, radiological and metabolomic function in patients who have been hospitalized for coronavirus infection (covid-19) in the period of a year: multicentric study (fenix)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-8j9kqy
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-06-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

others interstitial lung disease with fibrosis

Interventions

Observational Cohort Study including 270 discharged patients with Covid-19. They will followed every four months with clinical and laboratory assessment until one year
Other
R00-R99

Sponsors

Faculdade de Medicina de Botucatu
Lead Sponsor
Hospital Sírio-Libanês
Collaborator
Incor-HCFMUSP
Collaborator
Universidade Federal de Uberlândia
Collaborator
Escola Paulista de Medicina
Collaborator
Santa Casa de Araraquara
Collaborator
Hospital Estadual Américo Brasiliense
Collaborator
Hospital Estadual de Bauru
Collaborator
Hospital Beneficiência Portuguesa de Bauru
Collaborator
Faculdade de Medicina de Ribeirão Preto
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Age over 18 years;presence of characteristic symptoms of the disease in an acute form of COVID-19 with positive test with needed of hospitalization;hypoxemia proved during hospitalization;chest computed tomography scan with pulmonary involvement during hospitalization and signing the informed consent form

Exclusion criteria

Exclusion criteria: Patients with other virus diagnosis

Design outcomes

Primary

MeasureTime frame
It is expected to find variation in impairment of cardiopulmonary function through spirometry that can identify a drop in vital capacity and also in the volume of expiratory flow in the first second. Also through the diffusion of gases, we can identify reduced gas exchange as a complement to arterial blood gases. Finally, the six-minute walk test and the ergospirometry test can assess the maximum function of the cardiorespiratory system in subjects who were infected by covid-19;It is estimated that chest computed tomography is the tool capable of detecting pulmonary sequelae resulting from infection by Covid-19, which may be residual, persistent or progressive changes related to the covid-19 infection;It is estimated that by assessing the collected saliva, inflammation pathways can be assessed by metabolomic analysis in patients who were infected by covid-19

Secondary

MeasureTime frame
It is estimated that through the application of quality of life questionnaires, the impact of emotional stress can be assessed for the impairment of acute illness during the recovery of patients who were infected with covid-19;It is estimated that through the sequential clinical laboratory evaluation it is possible to identify patients who have new diagnoses after hospital discharge, such as thromboembolic events, nutritional changes, changes in muscle function, renal changes in subjects who were hospitalized for covid-19;It is estimated that through echocardiographic evaluation it is possible to assess and monitor possible functional changes resulting from infection by covid-19

Countries

Brazil

Contacts

Public ContactAndre ;Eloara Alburquerque;Campos

Incor-HCFMUSP;Escola Paulista de Medicina

drean.albuquerque@gmail.com;eloaravmf@yahoo.com.br(11) 97169-8770;11-981609069

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 12, 2026